Articles tagged "Kidney"

2020 American Transplant Congress
Analysis of Rejection, Rejection Therapy and Renal Function in the BEST Trial
H. Kuzaro¹, A. R. Shields², A. Wiseman³, S. Tremblay¹, A. Christianson¹, D. Kaufman⁴, J. Leone⁵, A. Matas⁶, P. West-Thielke⁷, R. R. Alloway¹, E. S. Woodle¹
¹U Cincinnati, Cincinnati, OH, ²The Christ Hospital, Cincinnati, OH, ³U Colorado, Denver, CO, ⁴U Wisconsin, Madison, WI, ⁵Tampa General, Tampa, FL, ⁶U Minnesota, Minneapolis, MN, ⁷UIC, Chicago, IL
*Purpose: The BEST Trial (Belatacept-based Early Steroid Withdrawal) compared two belatacept (BELA)-based early corticosteroid withdrawal (ESW) regimens and alemtuzumab (ALEM) or rabbit antithymocyte globulin (rATG)…
2020 American Transplant Congress
Establishment of a National Kidney Exchange Program in Mexico: Pro-Renal
A. Cicero¹, L. Basagoitia², E. F. Velez³, A. Dib-Kuri⁴, A. E. Roth⁵, M. A. Rees⁶
¹Transplant Surgery, ABC Medical Center, Mexico City, Mexico, ²Transplant Nephrology, Centro Mexicano Pro-Donación Renal, A.C., Mexico City, Mexico, ³Medical Director, Centro Mexicano Pro-Donación Renal, A.C., Mexico City, Mexico, ⁴Director, Centro Mexicano Pro-Donación Renal, A.C., Mexico City, Mexico, ⁵Department of Economics, Stanford University, Stanford, CA, ⁶Transplant Surgery, University of Toledo Medical Center, Toledo, OH
*Purpose: Expose the need of an effective kidney paired exchange program in Mexico*Methods: Describe how Pro-Renal works. Expose weaknesses of Mexican Health System. Compare our…
2020 American Transplant Congress
Once Weekly Fluconazole is Effective for the Prevention of Oral Candidiasis in Kidney Transplant Recipients
J. Lockridge, D. Roberts, K. Spence, M. Stack, S. Rehman, A. Olyaei
OHSU, Portland, OR
*Purpose: Oropharyngeal candidiasis is an infection prevalent in renal transplant recipients, with significant concerns for invasive endoscopic workup and development into invasive fungal infections. While…
2020 American Transplant Congress
Short Term Outcomes in Kidney Transplant Patients Receiving De Novo Belatacept with Anti-Thymocyte Globulin Induction
B. Carlson, P. Cabrera, T. Harrison, K. Tejani, A. Centeno
Pharmacy, Jackson Memorial Hospital, Miami, FL
*Purpose: Mainstay immunosuppressive therapy after kidney transplant is a calcineurin inhibitor (CNI) based regimen. Nephrotoxicity is a common adverse effect of CNIs which can lead…
2020 American Transplant Congress
Comparing Surgical and Urological Complications Over Time in Deceased Donor Kidney Transplantation
A. Mekhaimar, H. Maple, N. Mamode, R. H. Zakri, N. Kessaris
King's College London/Guy's and St Thomas' Hospital, London, United Kingdom
*Purpose: Despite advances in perioperative and post-transplant management over time, complications still occur following deceased donor (DD) kidney transplantation. This study aimed to determine the…
2020 American Transplant Congress
Predicting Kidney Discard among Donors Age 0-3: A Discard Risk Index
M. Joshi, M. Price, A. Rana
Baylor College of Medicine, Houston, TX
*Purpose: Among pediatric kidney donors the discard rate is highest among donors under 3-years-old. This study aims to identify factors predicting discard and construct a…
2020 American Transplant Congress
Significant Costs Associated with Poorly Controlled Post-Transplant Blood Glucose
H. Yerneni¹, K. Chavin², T. Srinivas¹, A. Padiyar¹
¹Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, ²Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: Dysglycemia is highly prevalent post-transplant. Poor glycemic control is associated with infectious and cardiovascular complications, as well as decreased patient and allograft survival. We…
2020 American Transplant Congress
Comparable Outcomes for Simultaneous Liver-Kidney Transplantation with HCV NAT-Positive Donors
M. L. Samoylova¹, B. I. Shaw¹, S. J. Kesseli¹, L. McElroy¹, Y. Patel², S. Sanoff², A. S. Barbas¹
¹Surgery, Duke University Hospital, Durham, NC, ²Medicine, Duke University Hospital, Durham, NC
*Purpose: To evaluate the impact of hepatitis C virus (HCV) Nucleic Acid Amplification-positive (NAT+) donors on outcomes following simultaneous liver-kidney (SLK) transplantation.*Methods: We used the…
2020 American Transplant Congress
Donor-Derived Cell-Free DNA Kinetics in Stable Kidney Transplant Patients Are Related to Donor/Recipient Variables
S. Anand, L. Dong, S. Dow, M. Fife, J. Krong, D. Morris, T. Srinivas
Intermountain Medical Center, Murray, UT
*Purpose: Donor-derived cell free DNA (dd-cfDNA) is increasingly used to monitor for allograft rejection. The relationship of dd-cfDNA to donor and recipient variables in not…
2020 American Transplant Congress
Transplant Surgery Continuing Professional Development Courses Increase Knowledge and Procedural Confidence
M. J. Hobeika¹, T. Menser², A. Kassam³, T. C. Rice⁴, T. S. Diwan³
¹Houston Methodist Hospital, Houston, TX, ²Houston Methodist Research Institute, Houston, TX, ³University of Cincinnati Medical Center, Cincinnati, OH, ⁴Washington University, St. Louis, MO
*Purpose: Continuing professional development (CPD) workshops are emerging to fill critical knowledge and skill gaps in both surgical trainees and practicing surgeons. The ASTS has…